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ABSTRACT
Summary: EPIMHC is a relational database of MHC-binding pep-
tides and T cell epitopes that are observed in real proteins. Currently,
the database contains 4867 distinct peptide sequences from vari-
ous sources, including 84 tumor-associated antigens. The EPIMHC
database is accessible through a web server that has been designed
to facilitate research in computational vaccinology. Importantly, pep-
tides resulting from a query can be selected to derive specific
motif-matrices. Subsequently, these motif-matrices can be used in
combination with a dynamic algorithm for predicting MHC-binding
peptides from user-provided protein queries.
Availability: The EPIMHC database server is hosted by the
Dana-Farber Cancer Institute at the site http://immunax.dfci.harvard.
edu/bioinformatics/epimhc/
Contact: reche@research.dfci.harvard.edu
INTRODUCTION
T cell immune responses are driven by antigenic peptides (T cell
epitopes) in the context of MHC molecules (Paul, 1998). Therefore,
comprehensive databases of MHC-binding peptides are important
tools for the analysis of binding to MHC molecules and the devel-
opment of peptide-based immunotherapies. Current examples of
databases of MHC-binding peptides include MHCPEP (Brusic et al.,
1998), SYFPEITHI (Rammensee et al., 1999), JenPep (Blythe
et al., 2002), MHCBN (Bhasin et al., 2003) and FIMM (Schonbach
et al., 2002). MHCPEP is the oldest database, and it has served
as the largest source of data for the other databases. Existing
resources have their limitations. In particular, MHCPEP has not
been updated since 1998. Peptide annotations in recent databases
have not been enhanced with regard to those in the MHCPEP data-
base, and the choices for extraction and analysis of the data are quite
limited.
In response to these limitations, we have created the EPIMHC
database. The database was compiled from peptides and annotations
collected from the above resources and the literature. MHC-binding
peptides obtained from SYFPEITHI were all considered to be high
binders. Peptide annotations in EPIMHC follow the basic scheme
of the MHCPEP database. However, EPIMHC only contains MHC-
binding peptides that occur in actual proteins, and it is structured as
a relational database of unique MHC<=>peptide-sequence pairs.
∗To whom correspondence should be addressed.
Also in EPIMHC, peptide annotations have been enhanced with
regard to related resources to include new information additional
to the usual MHC-binding specificity and T cell activity of pep-
tides. Most importantly, the processing of the peptide and its source
(organism and protein sequence) are also annotated in EPIMHC.
The processing field is to indicate whether MHC-binding peptides
are processed and presented from their protein sources in vivo (annot-
ated as natural). EPIMHC also provides links to relevant databases
such as PUBMED, IMGT/HLA and GenBank. The database contains
4875 distinct MHC-binding peptides, of which 2224 are T cell epi-
topes (1267 MHCI-restricted and 957 MHCII-restricted). Peptides
in the database target a total of 378 MHC specificities (226 MHCI
and 152 MHCII), the majority of which are human (176 MHCI and
119 MHCII). A functionally important subset of epitopes in the data-
base consists of 67 CD8+ and 17 CD4+ T cell epitopes derived from
tumor-associated antigens (TAAs).
EPIMHC can be accessed through a flexible web interface that
allows retrieval and display of data according to multiple criteria
(Fig. 1A). Result queries (Fig. 1B) can be saved in a variety of
TEXT formats. Unlike related databases, EPIMHC allows com-
putational experimentation. Specifically, peptides selected from
result queries (Fig. 1B) can be used to generate motif-matrices.
Subsequently, these motif-matrices can be used to predict related
sequences from a protein query using a dynamic search algorithm
(Fig. 1C and D). Motif-matrices are generated as position-specific
scoring matrices (PSSMs). PSSMs have previously been shown to
be adequate tools for prediction of peptide–MHC binding (Nielsen
et al., 2004; Reche et al., 2002, 2004). However, the prediction
results employing PSSMs are linked to the specific peptides used
to build the PSSM. Thus, the ‘create-matrix’ feature in EPIMHC
empowers users to carry out tailored prediction of MHC-binding
peptides. At the moment, PSSM can only be derived from peptides
of the same length. This size limitation together with structural fea-
tures of the peptide binding to MHC molecules (Reche et al., 2002,
2004) recommends applying the ‘create-matrix’ feature only to MHC
class I binding peptides.
In sum, databases of MHC-binding peptides are important tools
for studying T cell based immunorecognition. This utility has been
improved in EPIMHC by providing curated data, enhanced annota-
tions and a design that facilitates the extraction and analysis of data.
Furthermore, unlike any related resource, EPIMHC empowers the
users to derive their own predictors of MHC-binding, providing a
framework for tailored prediction of MHC-binding ligands.
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Fig. 1. (A) EPIMHC web interface. (B) Output from an example query (peptide binders to HLA-A*0205 of nine residues in length). Data can be saved in
various text formats. In this example, peptides eliciting T cell activity (epitopes) have been selected to create a motif-matrix. (C) Page resulting from selecting the
create matrix option. This page allows the prediction of MHC-binding peptides from a user-provided protein using the previously created PSSM. (D) Predicted
MHC-binding peptides at a 2% threshold from a prostate-specific membrane antigen (GenBank: A56881). Peptides highlighted in violet contain a C-terminus
predicted to result from immunoproteasomal cleavage (Reche et al., 2004).
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